For the first time, the United States is rolling out Covid vaccines updated to match variants that are currently dominant, as well as the original strain. This bivalent character will provide a better response not just to the most threatening variants today but probably to future variants too, because when the immune system faces different versions of the same virus it generates broader protections overall.